CSO, Neurala Biosciences
| Role | Organisation | Sources |
|---|---|---|
| Honorary Research Fellow | University of Melbourne | Forbes Australia |
| Founder | Psychae Therapeutics | Forbes Australia, Startup Daily, SmartCompany |
| CSO | Neurala Biosciences | LaunchVic |
Stories naming Dr Jerome Sarris. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Melbourne-based biotech Neurala Biosciences, founded by two researchers turning DMT and harmala compounds into medicines, covering its origins, grant and investor backing totalling $4.5m, and planned first-in-human studies.
Melbourne university funds backed a psychedelic medicines startup; six campus startups were showcased, and Tanarra Capital reported $100 million committed toward its alumni founders fund target.
Roundup of the week's Australian raises: Sitemate, Kashcade, Psychae Therapeutics, MediCann Health, Refilled and Upworth together banked $21.3 million across software, lending, psychedelic medicine, cannabis and drink dispensing.
Also Startup Daily·Startup Daily·SmartCompany·Forbes Australia